Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3Plasma cell 2Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 2265Precursor Cell Lymphoblastic Leukemia-Lymphoma 1734Leukemia 1500Leukemia, Lymphocytic, Chronic, B-Cell 1120Myelodysplastic Syndromes 963Hematologic Neoplasms 935Lymphoma 739Lymphoma, Non-Hodgkin 654Leukemia, Myelogenous, Chronic, BCR-ABL Positive 532Multiple Myeloma 501Lymphoma, Follicular 467Hodgkin Disease 460Lymphoma, Mantle-Cell 459Burkitt Lymphoma 440Lymphoma, Large B-Cell, Diffuse 433Lymphoma, B-Cell, Marginal Zone 402Recurrence 356Leukemia, Myelomonocytic, Chronic 351Myeloproliferative Disorders 330Leukemia, Myeloid, Chronic-Phase 311Lymphoma, Large-Cell, Immunoblastic 303Congenital Abnormalities 273Neoplasms 271Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 249Blast Crisis 246Leukemia, Myeloid, Accelerated Phase 244Primary Myelofibrosis 221Neoplasms, Plasma Cell 220Waldenstrom Macroglobulinemia 216Lymphoma, T-Cell, Cutaneous 197

Interventions

Lenalidomide 2ofatumumab 1Trimethoprim, Sulfamethoxazole Drug Combination 1SARS-CoV-2 inactivated vaccines 1Influenza Vaccines 1Immunoglobulins 1Clavulanic Acid 1Ciprofloxacin 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Agammaglobulinemia × Other hematologic neoplasm × Clear all
NCT05678621 2024-04-19

RATIONALISE

Monash University

Phase 2/3 Recruiting
300 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Agammaglobulinemia, Infections, Leukemia, Lymphoma, Neoplasms, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT01002755 2019-05-07

Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

M.D. Anderson Cancer Center

Phase 2 Completed
36 enrolled 7 charts
Classical hematologyLymphoidOther hematologic neoplasm

Lymphadenopathy, Agammaglobulinemia, Fatigue, Fever, Lymphocytosis, Paraproteinemias, Thrombocytopenia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01924169 2018-09-20

Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)

M.D. Anderson Cancer Center

Phase 2 Terminated
3 enrolled 7 charts
LymphoidOther hematologic neoplasm

Agammaglobulinemia, Hematologic Diseases, Influenza, Human, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡